Similarly, synergistic potentiation of low-dose 5-FU and TRAIL in TRAIL-resistant gastric adenocarcinoma cells revealed the mediation of DcR2 and DR5 in the activation of caspase cascades [73]. This evidence concerns the gene TNFRSF10D and gastric adenocarcinoma.